Pages that link to "Q36464587"
Jump to navigation
Jump to search
The following pages link to Replicating and non-replicating viral vectors for vaccine development (Q36464587):
Displaying 50 items.
- The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? (Q24652185) (← links)
- Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head (Q26783897) (← links)
- Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques (Q27319783) (← links)
- Protective immunity and safety of a genetically modified influenza virus vaccine (Q27324763) (← links)
- Sang Froid in a time of trouble: is a vaccine against HIV possible? (Q27487961) (← links)
- Retracted: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector (Q28533970) (← links)
- Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin (Q28731982) (← links)
- Estimating the Size of the U.S. Population at Risk of Severe Adverse Events from Replicating Smallpox Vaccine (Q30151714) (← links)
- Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. (Q30375160) (← links)
- Vaccine design for CD8 T lymphocyte responses (Q30411492) (← links)
- Novel viral vectored vaccines for the prevention of influenza (Q30418570) (← links)
- Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses (Q30427591) (← links)
- DNAVaxDB: the first web-based DNA vaccine database and its data analysis. (Q30841376) (← links)
- Development of a Streptococcus gordonii vaccine strain expressing Schistosoma japonicum Sj-F1 and evaluation of using this strain for intranasal immunization in mice (Q31110824) (← links)
- Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses (Q33686890) (← links)
- Development of replication-competent viral vectors for HIV vaccine delivery (Q33694226) (← links)
- Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. (Q33759392) (← links)
- A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy (Q33786140) (← links)
- Impact of ETIF deletion on safety and immunogenicity of equine herpesvirus type 1-vectored vaccines (Q34296144) (← links)
- Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice (Q34741882) (← links)
- Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges (Q35160124) (← links)
- Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction (Q35204547) (← links)
- Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs (Q35275117) (← links)
- Induction and comparison of SIV immunity in Ad5 naïve and Ad5 immune non-human primates using an Ad5 [E1-, E2b-] based vaccine (Q35317858) (← links)
- A cationic nanoemulsion for the delivery of next-generation RNA vaccines. (Q35600305) (← links)
- Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ (Q35826688) (← links)
- Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer (Q35949356) (← links)
- Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants (Q35973518) (← links)
- High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors. (Q35973549) (← links)
- Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones (Q36009232) (← links)
- Nonviral delivery of self-amplifying RNA vaccines (Q36221799) (← links)
- HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions (Q36249933) (← links)
- Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study (Q36621905) (← links)
- A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose (Q36736786) (← links)
- Recombinant adenovirus containing hyper-interleukin-6 and hepatocyte growth factor ameliorates acute-on-chronic liver failure in rats (Q36815008) (← links)
- Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability. (Q37060986) (← links)
- The novel replication-defective vaccinia virus (Tiantan strain)-based hepatitis C virus vaccine induces robust immunity in macaques (Q37181386) (← links)
- Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development. (Q37316026) (← links)
- HIV/AIDS vaccines: a need for new concepts? (Q37344236) (← links)
- Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques (Q37361294) (← links)
- Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development (Q37552015) (← links)
- Stable expression of a foreign protein by a replication-competent rubella viral vector (Q37640717) (← links)
- VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications. (Q37714030) (← links)
- Update on mucosal HIV vaccine vectors (Q37803319) (← links)
- Immunologic Basis of Vaccine Vectors (Q37804532) (← links)
- DNA Vaccines and Intradermal Vaccination by DNA Tattooing (Q37812301) (← links)
- DNA vaccines: an historical perspective and view to the future (Q37825523) (← links)
- Prospects for oral replicating adenovirus-vectored vaccines (Q38109356) (← links)
- Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines (Q38184579) (← links)
- Bovine adenovirus-3 as a vaccine delivery vehicle. (Q38286656) (← links)